Skip to main content

Table 4 Blood pressure changes after fimasartan treatment (STEP II)

From: Clinical characteristics and satisfaction with the fimasartan in Korean hypertensive patients: a prospective, cross-sectional and open-label, 8-week switching study (Kanarb-hypertension epidemiology medication satisfaction study; K-HEMS study)

Analysis Points

 

Systolic Blood Pressure (SBP)

Diastolic Blood Pressure (DBP)

Baseline

n

2006

2006

Mean ± SD

135.7 ± 17.9

82.1 ± 11.5

End of Study

n

1930

1928

Mean ± SD

128.6 ± 13.1

79.1 ± 8.4

Change (End of Study – Baseline)

n

1914

1912

Mean ± SD

−6.8 ± 18.4

−3.1 ± 11.6

 

p-value

< 0.0001

< 0.0001

  1. Tested by paired t-test